A detailed history of Capitol Family Office, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Capitol Family Office, Inc. holds 3,247 shares of LLY stock, worth $2.88 Million. This represents 3.93% of its overall portfolio holdings.

Number of Shares
3,247
Previous 3,489 6.94%
Holding current value
$2.88 Million
Previous $2.71 Million 8.29%
% of portfolio
3.93%
Previous 3.51%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

SELL
$724.87 - $909.04 $175,418 - $219,987
-242 Reduced 6.94%
3,247 $2.94 Million
Q1 2024

Apr 15, 2024

SELL
$592.2 - $792.28 $92,975 - $124,387
-157 Reduced 4.31%
3,489 $2.71 Million
Q4 2023

Jan 09, 2024

SELL
$525.19 - $619.13 $100,836 - $118,872
-192 Reduced 5.0%
3,646 $2.13 Million
Q3 2023

Oct 10, 2023

BUY
$434.7 - $599.3 $1.67 Million - $2.3 Million
3,838 New
3,838 $2.06 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $843B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Capitol Family Office, Inc. Portfolio

Follow Capitol Family Office, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capitol Family Office, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capitol Family Office, Inc. with notifications on news.